{"id":101679,"date":"2020-09-28T08:51:17","date_gmt":"2020-09-28T08:51:17","guid":{"rendered":"https:\/\/www.edristi.in\/?p=101679"},"modified":"2020-09-28T08:51:19","modified_gmt":"2020-09-28T08:51:19","slug":"dr-reddys-launches-generic-drug-to-treat-multiple-sclerosis-in-us","status":"publish","type":"post","link":"https:\/\/www.edristi.in\/hi\/%e0%a4%b9%e0%a5%8b%e0%a4%ae\/dr-reddys-launches-generic-drug-to-treat-multiple-sclerosis-in-us\/","title":{"rendered":"Dr Reddy&#8217;s launches generic drug to treat multiple sclerosis in US"},"content":{"rendered":"\n<p class=\"wp-block-paragraph\"><strong>Question : Multiple sclerosis (MS) is a potentially disabling disease of the \u2013<\/strong><br>(a) brain and spinal cord (central nervous system)<br>(b) intestines<br>(c) heart, arteries and veins<br>(d) kidneys<br><strong>Answer (a)<br>Related facts<\/strong><\/p>\n\n\n\n<ul class=\"wp-block-list\"><li>Dr Reddy&#8217;s Laboratories on Saturday(26 September 2020) said it has launched Dimethyl Fumarate delayed-release capsules, used to treat multiple sclerosis (MS), in the US market.<\/li><li>The company&#8217;s product is a therapeutic equivalent generic version of Biogen&#8217;s Tecfidera delayed-release capsules, the Hyderabad-based drug firm said in a statement.<\/li><li>According to IQVIA Health data, the Tecfidera brand and generic market had sales of around USD 3.8 billion (about Rs 28,000 crore) in the US for the most recent twelve months ending in June 2020.<\/li><li>Multiple sclerosis (MS) is a potentially disabling disease of the brain and spinal cord (central nervous system).<\/li><\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">In MS, the immune system attacks the protective sheath (myelin) that covers nerve fibers and causes communication problems between our brain and the rest of our body.<\/p>\n\n\n\n<p class=\"has-text-align-right wp-block-paragraph\"><strong>By &#8212; Pankaj Pandey.<\/strong><\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Link:<\/strong><br><a href=\"https:\/\/economictimes.indiatimes.com\/industry\/healthcare\/biotech\/pharmaceuticals\/dr-reddys-launches-generic-drug-to-treat-multiple-sclerosis-in-us\/articleshow\/78333782.cms\" target=\"_blank\" rel=\"noreferrer noopener\">https:\/\/economictimes.indiatimes.com\/industry\/healthcare\/biotech\/pharmaceuticals\/dr-reddys-launches-generic-drug-to-treat-multiple-sclerosis-in-us\/articleshow\/78333782.cms<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Question : Multiple sclerosis (MS) is a potentially disabling disease of the \u2013(a) brain and spinal cord (central nervous system)(b) intestines(c) heart, arteries and veins(d) kidneysAnswer (a)Related facts Dr Reddy&#8217;s Laboratories on Saturday(26 September 2020) said it has launched Dimethyl Fumarate delayed-release capsules, used to treat multiple sclerosis (MS), in the US market. The company&#8217;s [&hellip;]<\/p>\n","protected":false},"author":9,"featured_media":101680,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1123],"tags":[3067],"class_list":["post-101679","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-snes","tag-scientific"],"_links":{"self":[{"href":"https:\/\/www.edristi.in\/hi\/%e0%a4%b9%e0%a5%8b%e0%a4%ae\/wp-json\/wp\/v2\/posts\/101679","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.edristi.in\/hi\/%e0%a4%b9%e0%a5%8b%e0%a4%ae\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.edristi.in\/hi\/%e0%a4%b9%e0%a5%8b%e0%a4%ae\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.edristi.in\/hi\/%e0%a4%b9%e0%a5%8b%e0%a4%ae\/wp-json\/wp\/v2\/users\/9"}],"replies":[{"embeddable":true,"href":"https:\/\/www.edristi.in\/hi\/%e0%a4%b9%e0%a5%8b%e0%a4%ae\/wp-json\/wp\/v2\/comments?post=101679"}],"version-history":[{"count":1,"href":"https:\/\/www.edristi.in\/hi\/%e0%a4%b9%e0%a5%8b%e0%a4%ae\/wp-json\/wp\/v2\/posts\/101679\/revisions"}],"predecessor-version":[{"id":101681,"href":"https:\/\/www.edristi.in\/hi\/%e0%a4%b9%e0%a5%8b%e0%a4%ae\/wp-json\/wp\/v2\/posts\/101679\/revisions\/101681"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.edristi.in\/hi\/%e0%a4%b9%e0%a5%8b%e0%a4%ae\/wp-json\/wp\/v2\/media\/101680"}],"wp:attachment":[{"href":"https:\/\/www.edristi.in\/hi\/%e0%a4%b9%e0%a5%8b%e0%a4%ae\/wp-json\/wp\/v2\/media?parent=101679"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.edristi.in\/hi\/%e0%a4%b9%e0%a5%8b%e0%a4%ae\/wp-json\/wp\/v2\/categories?post=101679"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.edristi.in\/hi\/%e0%a4%b9%e0%a5%8b%e0%a4%ae\/wp-json\/wp\/v2\/tags?post=101679"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}